NCT05664191View on ClinicalTrials.gov

Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

April 13, 2026

Study Completion Date

April 13, 2026

Conditions
Sub-arachnoid Haemorrhage
Interventions
DRUG

Levosimendan

Infusion at 0.1 µg/kg/min at day 1 and day 8

OTHER

Placebo

Glucose 5%, solution for injection ECOFLAC at day 1 and day 8

Trial Locations (1)

75010

RECRUITING

Hôpital Lariboisière, Service d'anesthésie Réanimation, Paris

All Listed Sponsors
collaborator

Orion Corporation, Orion Pharma

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER